Comprehensive Preclinical Evaluation of the VLP Vaccine “Gam-VLP-rota” Following Single-Dose Administration: Hematology, Biochemistry, and Histopathology in Sprague–Dawley Rats (Part II)
Abstract
Background. Rotavirus infection remains a major cause of severe gastroenteritis in children worldwide. Virus-like particle (VLP)-based vaccines are considered a promising non-replicating alternative to live vaccines due to their favorable safety profile.
Objective. To evaluate the acute toxicity of the VLP-based vaccine “Gam-VLP-rota” following single intramuscular administration in Sprague–Dawley (SD) rats.
Materials and Methods. Male and female SD rats were allocated into four experimental groups (vehicle control; 30, 120, and 600 µg antigen per animal; n = 14 per sex per group). The vaccine was administered once into the quadriceps femoris muscle (0.2 mL per animal). Animals were euthanized either 24 h after administration (Day 2) or after a 14-day recovery period (Day 15). Clinical condition, body weight, and food consumption were monitored. Hemostasis parameters, hematology, serum biochemistry, bone marrow cellular composition, organ weights, necropsy findings, histopathology, and local tolerability were evaluated.
Results. No mortality or severe clinical manifestations were observed. On Day 2, transient intergroup differences in body weight gain and moderate reduction in food intake were detected in animals receiving the highest antigen dose (600 µg). These parameters normalized by Days 7–15. Reversible changes in hemostasis were recorded, including prolonged prothrombin time and elevated fibrinogen levels. Hematological analysis on Day 2 demonstrated dose-dependent…
Read the paper
Related studies
- Patient-Centered Pharmaceutical Design to Improve Acceptability of Medicines: Similarities and Differences in Paediatric and Geriatric Populations
- Evidence-based clinical practice guidelines for irritable bowel syndrome 2020
- Phase 2b Study of Pimodivir (JNJ-63623872) as Monotherapy or in Combination With Oseltamivir for Treatment of Acute Uncomplicated Seasonal Influenza A: TOPAZ Trial
- Gastrointestinal manifestations in COVID-19
- COVID-19 and Gastrointestinal Disease: Implications for the Gastroenterologist
- Persistent gut barrier damage and commensal bacterial influx following eradication of Giardia infection in mice
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.